Hexagon Capital Partners’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6	Closed	-$196	–	1427
2023 Q2	$196	Hold	6	–	–	﹤0.01%	1350
2023 Q1	$211	Hold	6	–	–	﹤0.01%	1350
2022 Q4	$275	Buy	+6	New	+$275	﹤0.01%	1357